A new drug called donanemab is showing promise in the fight against Alzheimer's disease. In a global trial, the drug has been found to slow cognitive decline in patients with early-stage Alzheimer's. Donanemab works by clearing a protein that builds up in the brains of people with Alzheimer's. While it is not a cure, the results mark a new era in treating Alzheimer's. It is currently being assessed by the UK's drugs watchdog for possible NHS use. Read more: https://lnkd.in/gEWSrb-D #medicalscience #Alzheimer #drugdevelopment #biology #medicine
Great hope for people with alzeimers and their closed ones, kudos to the team 👏
Thanks for Sharing! 😁 Dianox